Specify a stock or a cryptocurrency in the search bar to get a summary
BCAL Diagnostics Ltd
BDXBCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTEST, a laboratory developed test or in-house in vitro diagnostic blood test. The company was incorporated in 2010 and is headquartered in Sydney, Australia. Address: 50 Clarence Street, Sydney, NSW, Australia, 2000
Analytics
WallStreet Target Price
0.31 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BDX
Dividend Analytics BDX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BDX
Stock Valuation BDX
Financials BDX
Results | 2019 | Dynamics |